A Study of AS-101 in Patients With AIDS or AIDS Related Complex (ARC)

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

Not specified

Study Completion Date

March 31, 1993

Conditions
HIV Infections
Interventions
DRUG

AS-101

Trial Locations (1)

10029

Mount Sinai Med Ctr, New York

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00001006 - A Study of AS-101 in Patients With AIDS or AIDS Related Complex (ARC) | Biotech Hunter | Biotech Hunter